Press Releases

Creative Peptides Provides Synthetic Peptides for Developing Vaccines

The Chemistry-Focused Technology Platform Is Optimized at Alfa Chemistry

Alfa Chemistry, the US-located chemical supplier, has recently announced that it has finished the optimization work of its chemistry-focused technology platform, which enables the company to offer a comprehensive range of services such as synthetic chemistry, chiral separations, small molecule synthesis, peptide, nucleoside, fluorinated building blocks, milligram preparation, kilogram GLP scale-up, reagent service, and compound management.

AI & Medicine Develops Medical Therapy and Research System to Facilitate Disease Treatment

AI & Medicine, one of the forerunners in the AI-assisted medicine area, announces that it has successfully developed a medical therapy and research system, which can assist in disease treatment, health management, adjuvant therapy, and deep mining of public document database.

Rho Experts Share Approach for Maximizing Benefits of Decentralized Trials During Free Webinar

Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, will discuss its approach to and solutions for maximizing the benefits of decentralized clinical trials in an upcoming webinar, “CROs: The Tip of the Spear in Maximizing the Value of Hybrid, Virtual, and Synthetic Clinical Trials.” The webinar will take place on Wednesday, August 26, from 1-2 p.m. EST.

ERT and Science 37® Partner to Deliver High-Quality Data during Virtual Trials

Technology partnership enables trial sponsors to improve imaging, respiratory, and cardiac safety data quality while reducing patient burden and risk

Optogenetics Services Now Available at Profacgen

BOC Sciences Launched Its PROTACs Technology Platform to Assist Drug Development

Panthera further extends its network of clinical trial sites with the opening of a clinical trial site in North London in collaboration with Medicus Health Partners

Panthera’s network of UK clinical trials sites grows to seven with several others in development.

eClinical Solutions’ Clinical Data Management Leaders to Co-Chair and Present at Society of Clinical Data Management (SCDM) 2020 Virtual Conference

Industry leaders to discuss the journey from data management to data sciences, present case studies on how technology platforms are automating and improving data review and reconciliation at world’s largest clinical data management conference

Lifeasible Offers Customized One-stop Service for Seed Testing

Creative Biostructure Released Fluorescence Resonance Energy Transfer (FRET) Assay

Matexcel Updated Its Bioglass Products Recently

Creative BioMart Provides a Complete Set of Protein Engineering Services

Alfa Chemistry—a Trust-Worthy Supplier of Analytical Chemistry Reagents

Alfa Chemistry announced to provide varieties of analytical chemical reagents, which could be widely used in multiple applications, such as chromatography, spectroscopy, titration (including Karl Fischer titration, acid-base titration, etc.), food microbiology, microscopy, water quality analysis, gravimetry and other analytical applications.

CluePoints Joins Forces with Global Growth Investor Summit Partners to Expand Market Leadership Position in Risk-Based Quality Management

CluePoints S.A., a provider of Risk-Based Study Execution (RBx) and Data Quality Oversight software for clinical trials, today announced a minority investment from Summit Partners, a global growth equity investor with $21 billion in assets under management. Summit will support the company’s continued growth and global expansion to meet accelerating customer demand worldwide.

Atorus Research Announces Release of Second R Package

Atorus Research, a clinical analytics company that builds tools and solutions that efficiently facilitate data management and biometric activities, is pleased to announce the release of their second R package, Tplyr.

Patients Receive New Potential Treatment for Severe Pneumonia Associated with COVID-19

BioAegis partners with EastHORN Clinical Services on COVID-19 Program

ANA Therapeutics and Quotient Sciences Announce Partnership to Manufacture Niclosamide Drug Candidate as a Potential Treatment for COVID-19

ANA Therapeutics and Quotient Sciences today announced a partnership to support the manufacturing of ANA Therapeutics’ drug candidate, ANA001 (niclosamide capsules), which they are developing as a potential treatment for COVID-19. As part of the collaboration, Quotient will scale up the capsule formulation, characterize and optimize the manufacturing process and ensure continuity of drug product through clinical trials.

Creative Biolabs’ Oncolytic Virus Construction Services Help to Shape the Future of Oncolytic Virotherapy

As a novel strategy for treatment of tumors, oncolytic virotherapy attracts many attention from global researchers. As a world-leading expert in the field of oncolytic virus, Creative Biolabs has executed every strategy to optimize its virus construction services.

THREAD Accelerates Expansion to Advance Global Decentralized Clinical Trials

Innovative Technology and Service Provider Receives Additional $50 Million Capital Commitment from Water Street and JLL Partners